PRAX logo

PRAX Cash From Financing

Annual CFF:

$514.32M+$422.45M(+459.83%)
December 31, 2024

Summary

  • As of today, PRAX annual cash from financing is $514.32 million, with the most recent change of +$422.45 million (+459.83%) on December 31, 2024.
  • During the last 3 years, PRAX annual cash from financing has risen by +$406.74 million (+378.06%).
  • PRAX annual cash from financing is now at all-time high.

Performance

PRAX Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPRAXcash flow metrics

Quarterly CFF:

$6.44M-$21.88M(-77.27%)
September 30, 2025

Summary

  • As of today, PRAX quarterly cash from financing is $6.44 million, with the most recent change of -$21.88 million (-77.27%) on September 30, 2025.
  • Over the past year, PRAX quarterly cash from financing has increased by +$5.29 million (+459.74%).
  • PRAX quarterly cash from financing is now -97.02% below its all-time high of $216.09 million, reached on June 30, 2024.

Performance

PRAX Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPRAXcash flow metrics

TTM CFF:

$203.32M+$5.29M(+2.67%)
September 30, 2025

Summary

  • As of today, PRAX TTM cash from financing is $203.32 million, with the most recent change of +$5.29 million (+2.67%) on September 30, 2025.
  • Over the past year, PRAX TTM cash from financing has dropped by -$200.26 million (-49.62%).
  • PRAX TTM cash from financing is now -60.47% below its all-time high of $514.32 million, reached on December 31, 2024.

Performance

PRAX TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPRAXcash flow metrics

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

PRAX Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+459.8%+459.7%-49.6%
3Y3 Years+378.1%+105.1%+1592.1%
5Y5 Years+751.7%-94.1%+33.7%

PRAX Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+4814.7%-97.0%+2634.3%-60.5%+2006.1%
5Y5-Yearat high+4814.7%-97.0%+2634.3%-60.5%+2185.6%
All-TimeAll-Timeat high+4814.7%-97.0%+121.3%-60.5%+2185.6%

PRAX Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2025
-
$6.44M(-77.3%)
$203.32M(+2.7%)
Jun 2025
-
$28.32M(-47.5%)
$198.04M(-48.7%)
Mar 2025
-
$53.97M(-52.9%)
$385.80M(-25.0%)
Dec 2024
$514.32M(+459.8%)
$114.60M(+9865.4%)
$514.32M(+27.4%)
Sep 2024
-
$1.15M(-99.5%)
$403.59M(+0.3%)
Jun 2024
-
$216.09M(+18.4%)
$402.18M(+57.4%)
Mar 2024
-
$182.49M(+4621.5%)
$255.52M(+181.2%)
Dec 2023
$91.87M(+777.9%)
$3.87M(+1621.7%)
$90.87M(-1.4%)
Sep 2023
-
-$254.00K(-100.4%)
$92.16M(-3.6%)
Jun 2023
-
$69.42M(+289.4%)
$95.55M(+263.3%)
Mar 2023
-
$17.83M(+245.9%)
$26.30M(+172.4%)
Dec 2022
$10.46M
$5.15M(+64.2%)
$9.65M(-19.7%)
DateAnnualQuarterlyTTM
Sep 2022
-
$3.14M(+1663.5%)
$12.02M(+35.1%)
Jun 2022
-
$178.00K(-85.0%)
$8.90M(-91.8%)
Mar 2022
-
$1.18M(-84.3%)
$107.92M(+1.0%)
Dec 2021
$107.59M(-64.7%)
$7.52M(>+9900.0%)
$106.82M(-64.5%)
Sep 2021
-
$19.00K(-100.0%)
$301.19M(-26.5%)
Jun 2021
-
$99.20M(>+9900.0%)
$409.90M(+22.7%)
Mar 2021
-
$91.00K(-100.0%)
$333.98M(+10.0%)
Dec 2020
$304.42M(+404.1%)
$201.88M(+85.7%)
$303.72M(+99.7%)
Sep 2020
-
$108.73M(+367.2%)
$152.12M(+250.6%)
Jun 2020
-
$23.27M(+177.1%)
$43.39M(+115.7%)
Mar 2020
-
-$30.17M(-160.0%)
$20.11M(-60.0%)
Dec 2019
$60.39M(+59.7%)
$50.28M
$50.28M
Dec 2018
$37.80M
-
-

FAQ

  • What is Praxis Precision Medicines, Inc. annual cash from financing?
  • What is the all-time high annual cash from financing for Praxis Precision Medicines, Inc.?
  • What is Praxis Precision Medicines, Inc. annual cash from financing year-on-year change?
  • What is Praxis Precision Medicines, Inc. quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Praxis Precision Medicines, Inc.?
  • What is Praxis Precision Medicines, Inc. quarterly cash from financing year-on-year change?
  • What is Praxis Precision Medicines, Inc. TTM cash from financing?
  • What is the all-time high TTM cash from financing for Praxis Precision Medicines, Inc.?
  • What is Praxis Precision Medicines, Inc. TTM cash from financing year-on-year change?

What is Praxis Precision Medicines, Inc. annual cash from financing?

The current annual cash from financing of PRAX is $514.32M

What is the all-time high annual cash from financing for Praxis Precision Medicines, Inc.?

Praxis Precision Medicines, Inc. all-time high annual cash from financing is $514.32M

What is Praxis Precision Medicines, Inc. annual cash from financing year-on-year change?

Over the past year, PRAX annual cash from financing has changed by +$422.45M (+459.83%)

What is Praxis Precision Medicines, Inc. quarterly cash from financing?

The current quarterly cash from financing of PRAX is $6.44M

What is the all-time high quarterly cash from financing for Praxis Precision Medicines, Inc.?

Praxis Precision Medicines, Inc. all-time high quarterly cash from financing is $216.09M

What is Praxis Precision Medicines, Inc. quarterly cash from financing year-on-year change?

Over the past year, PRAX quarterly cash from financing has changed by +$5.29M (+459.74%)

What is Praxis Precision Medicines, Inc. TTM cash from financing?

The current TTM cash from financing of PRAX is $203.32M

What is the all-time high TTM cash from financing for Praxis Precision Medicines, Inc.?

Praxis Precision Medicines, Inc. all-time high TTM cash from financing is $514.32M

What is Praxis Precision Medicines, Inc. TTM cash from financing year-on-year change?

Over the past year, PRAX TTM cash from financing has changed by -$200.26M (-49.62%)
On this page